Edesa Biotech Inc
PublicEdesa Biotech Inc is now publicly traded
The data on this page reflects Edesa Biotech Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Jun 26, 2026
Total Funding Raised
$3.5M
Company Overview
Edesa Biotech Inc is a clinical-stage biopharmaceutical company that develops targeted therapies for inflammatory and immune-related diseases.
Sector
Healthcare
AI Layer
Non-AI
Keywords
biopharmaceuticalmonoclonal antibodyacute respiratory distress syndromeARDSclinical stagedrug developmentclinical trialinflammatory diseasebiotechdrug pipelineallergic contact dermatitistherapeuticout-licensingbiologicsnon-dilutive funding
Edesa Biotech Inc Comparables
Compare Edesa Biotech Inc with similar companies based on industry and business-model similarity.
Edesa Biotech Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jun 26, 2026 |
Edesa Biotech Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersCanada
Employee Range22
Year Founded2015
Last FundingJun 26, 2026
See something wrong or outdated?